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The goal of this study was to assess fibrinolytic activity after vessel 
wall injury and to correlate changes in fibrinolytic activity with 
angiographic and histologic findings. Accordingly, in 18 athero· 
sclerotic rabbits, vessel wall injury was produced by means of iliac 
artery balloon angioplasty (the injury group), whereas 8 athero· 
sclerotic rabbits served as a control group. In all rabbits from the 
injury group, deep vessel wall injury was documented by either 
angiography or histologic study. Plasminogen activator inhibi· 
tor-1 activity in plasma increased significantly, from 21.79 ± 1.29 
arbitrary units/ml (AU/ml) at baseline study to 32.05 ± 1.47 
AU/ml at 6 h after vessel wall injury (p < 0.01), whereas activity 
remained unchanged throughout the 24-h period in the control 
Acute coronary syndromes are associated with several pro-
coagulant mechanisms that lead to intracoronary thrombosis 
and impaired coronary blood flow. Plasma levels of plasmi-
nogen activator inhibitor-! have been found to be elevated 
both in acute myocardial infarction and, more recently, in 
unstable angina at rest (1). These clinical observations raise 
the possibility that vascular wall injury such as plaque 
fissuring may be responsible for impaired fibrinolytic activ-
ity. Accordingly, the goals of this study were to 1) assess 
fibrinolytic activity after vascular wall damage in an exper-
imental model of arterial injury, and 2) correlate changes in 
fibrinolytic activity with angiographic and histologic find-
ings. 
Methods 
Experimental protocol. Twenty-six New Zealand White 
rabbits were fed an atherogenic diet consisting of 1% cho-
lesterol and 3% peanut oil. After 6 weeks, the animals were 
randomized to either the injury group (n = 18) or the control 
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group. Plasma levels of tissue plasminogen activator activity were 
similar in both groups. Intravascular thrombus was found in five 
of six additional rabbits 6 h after vessel wall injury, that is, at the 
time of impaired fibrinolytic activity, whereas no thrombus was 
found in the control group (p < 0.05). 
It is concluded that deep vessel wall injury is associated with 
reduced fibrinolytic activity. In addition to other procoagulant 
factors, elevated plasminogen activator inhibitor-! activity may 
lead to intravascular thrombosis and impaired resolution of 
thrombus. 
(JAm Coli Cardio/1992;19:441-3) 
group (n = 8). All rabbits were anesthetized with an intra-
muscular injection of 35 mg/kg body weight ketamine. The 
injury group was subjected to vessel wall injury by means of 
bilateral common iliac artery angioplasty using a 3-mm 
balloon catheter. The control group underwent the same 
handling, anesthetic procedures and blood sampling as the 
injury group. Because our preliminary observations (unpub-
lished data) indicated that vascular trauma during arterial 
cannulation and surgical exposure of the arterial vessels are 
associated with a transient increase in plasminogen activator 
inhibitor-!, those procedures (except for venipuncture) were 
prohibited in the control group. Peripheral angiography was 
performed immediately after balloon injury in nine rabbits 
from the injury group. The surgical and angiographic proce-
dures were carried out under sterile conditions. The angio-
graphic variables analyzed include the presence and length 
of vessel wall dissection and the presence of an intravascular 
thrombus. The rabbits were allowed to recover and were 
killed 4 weeks later. The animal experiments conform to the 
"Position of the American Heart Association on Research 
Animal Use" adopted November 11, 1984. 
Biochemical assays. Blood samples were obtained from 
the ear vein at baseline and at 1, 6 and 24 h after the vessel 
injury and at the same time intervals in the control group. To 
account for possible circadian variations in measured varia-
bles, the time of blood sampling was matched in the two 
groups (±2 h). Venous blood (0.9 ml) and sodium citrate 
(0.1 ml, 0.13 M; pH 7.5) were mixed, placed on ice and 
centrifuged (2,000 g for 5 min at 4°C). For measurements of 
tissue plasminogen activator (t-PA) activity, the citrated 
plasma samples were immediately acidified with sodium 
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acetate buffer (1 M; pH 3.9). The acidified and citrated 
plasma samples were stored at -70°C until analyzed. 
Plasminogen activator inhibitor-! and t-PA activities were 
determined by chromogenic assay as described before (1 ,2). 
Plasminogen activator inhibitor-! activity was expressed in 
arbitrary units (AU)/ml. One arbitrary unit of plasminogen 
activator inhibitor-! is defined as the amount that inhibits 
1 IV of t-PA activity for 15 min. 
Histology. With use of in situ perfusion fixation with a 4% 
formaldehyde solution, iliac arteries in nine rabbits of the 
injury group were preserved for histologic study. Arteries 
were sectioned (every 4 mm), dehydrated in graded ethanol 
and embedded in paraffin. Sections from each block were 
stained with hematoxylin-eosin, trichrome (for connective 
tissue) and Verhoeff-van Gieson stains (for elastic fibers). In 
six additional atherosclerotic rabbits, histologic features of 
the iliac artery were assessed at 6 h after vessel wall injury 
(that is, at the time of maximal changes in the fibrinolytic 
activity) and compared with those of three control rabbits 
not subjected to the balloon injury. Variables analyzed by 
light microscopy included the presence of deep vessel wall 
injury (defined as a disruption of the internal elastic lamellae) 
and intravascular thrombus. Microscopic evaluation was 
performed by an observer who had no knowledge of the 
randomization data. 
Statistical analysis. All results are expressed as mean 
values ± SEM. The biochemical data in the control and 
injury groups were analyzed with use of two-way analysis of 
variance. Subsequent comparisons between the groups or 
different sampling times were carried out with the unpaired 
and paired t tests and Bonferroni correction for multiple 
group comparisons; the Fisher exact test was used to com-
pare the incidence of intravascular thrombus. 
Results 
Plasma t-PA and plasminogen activator inhibitor-1 activ-
ity. Baseline t-PA activity in plasma was 13.53 ± 2.07 IU/ml 
in the control group and 11.89 ± 1.02 IU/ml in the injury 
group (p = NS) (Fig. 1). Tissue plasminogen activator 
activity did not change significantly throughout the experi-
ment within the groups, nor did it differ significantly between 
the control and injury groups. Baseline plasminogen activa-
tor inhibitor-! activity in plasma was 21.8 ± 1.34 AU/ml in 
the control group and 21.79 ± 1.29 AU!ml in the treated 
group (p = NS) (Fig. 2). In the control group, plasminogen 
activator inhibitor-! activity remained unchanged at 1, 6 and 
24 h. In contrast, in the injury group, plasminogen activator 
inhibitor-! activity increased to 32.05 ± 1.47 AU/ml at 6 h 
(p < 0.01 vs. the control group at baseline and at 1, 6 and 
24 h) and returned to baseline at 24 h (23.99 ± 1.16 AU/ml). 
Plasminogen activator inhibitor-! activity at 6 h after vessel 
wall injury was significantly higher than at any other time in 
the injury group (p < 0.01) (Fig. 2). 
Angiography. Seven of the nine rabbits from the injury 
group subjected to peripheral angiography demonstrated 
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Figure 1. Levels of tissue plasminogen activator (t-PA) in plasma in 
the control group (n = 8) (open circles) and in the injury group (n = 
18) (closed circles) are comparable. 
iliac artery dissection. There was no correlation between the 
length of dissection and the level of maximal plasminogen 
activator inhibitor-! activity (r = 0.35, p = NS). In addition, 
only three of the nine rabbits showed intravascular thrombus 
immediately after vessel wall injury. 
Histology. Of the nine rabbits from the injury group that 
were studied by light microscopy 4 weeks after the proce-
dure, all showed signs of deep vessel wall injury (disruption 
of the internal elastic lamellae, smooth muscle cell prolifer-
ation and foci of fibrosis). Intravascular thrombus was found 
in five of six additional rabbits evaluated 6 h after vessel wall 
injury (that is, at the time of impaired fibrinolytic activity) 
(Fig. 2) , whereas three control rabbits showed intact internal 
elastic lamellae and no thrombus formation (p < 0.05). 
Figure 2. Plasminogen activator inhibitor-} (PAI-l) activity in 
plasma is significantly increased at 6 h after vessel wall injury. *p < 
0.01 compared with activity levels at baseline and at 1, 6 and 24 h in 
the control group (open circles) and at baseline and at 1 and 24 h in 
the injury group (closed circles). AU = arbitrary units. 
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Discussion 
The major finding of this study was that deep vessel wall 
injury resulted in transient elevation of plasminogen activa-
tor inhibitor-! activity. Furthermore, a temporal relation 
between impaired fibrinolytic activity and increased inci-
dence of intravascular thrombus was observed. 
Mechanism of plasminogen activator inhibitor elevation. 
An increase in plasminogen activator inhibitor-! activity 
after vessel wall injury could be related either to direct 
release of plasminogen activator inhibitor-! from the acti-
vated platelets or to its enhanced de novo synthesis stimu-
lated by released growth factors. The latter was recently 
demonstrated both in vitro (3) and in vivo (4). Platelet ly-
sates increased plasminogen activator inhibitor-! activity, 
whereas antibodies to transforming growth factor beta mark-
edly attenuated this response (4). The alternative mechanism 
may involve conformational change in the plasminogen 
activator inhibitor-! molecule after vessel wall injury. The 
exposure of extracellular matrix to a variety of binding 
proteins could lead to conversion of the latent plasminogen 
activator inhibitor-! to its active form (5). Because plasmi-
nogen activator inhibitor-! activity increased in the injury 
group, but not in the control rabbits, the possibility of in 
vitro release of the inhibitor in collected anticoagulated 
blood samples was excluded. To avoid bacterial contamina-
tion, all surgical procedures were carried out under sterile 
conditions; therefore, an endotoxin-induced increase in plas-
minogen activator inhibitor-! activity seems unlikely (6). 
Pathophysiologic effects of plasminogen activator inhibi-
tor-! elevation. The exact cause and effect relation between 
increased plasminogen activator inhibitor-! activity and in-
travascular thrombosis has not been entirely determined, 
although high plasma levels of the inhibitor have been 
accompanied by prolonged clot lysis (7). Elevated plasmino-
gen activator inhibitor-! activity has been associated with 
failure of thrombolytic therapy to achieve sustained reper-
fusion in acute myocardial infarction (8) and with increased 
risk of reinfarction over a long follow-up period (9). Further-
more, our previous study (1) in patients with unstable angina 
demonstrated that impaired fibrinolytic activity was associ-
ated with a 50% incidence rate of intracoronary thrombus at 
the site of vessel wall injury by coronary angiography. The 
present study suggests a procoagulant role of elevated 
plasma levels of plasminogen activator inhibitor-!, as indi-
cated by microscopic evidence of intravascular thrombosis 
at the time of impaired fibrinolytic activity. 
Experimental model and limitations. There are several 
limitations of this study. To achieve medial injury, the iliac 
artery was intentionally injured with an oversized balloon. 
Therefore, the extent of impairment of fibrinolytic activity in 
lesser forms of vessel wall injury remains to be determined. 
Furthermore, this study did not address the exact location of 
plas~inogen activator inhibitor-! formation (for example, at 
the s1te of iliac artery dissection or arteriotomy). However, 
our results indicate that vessel wall injury in conjunction 
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with elevated plasminogen activator inhibitor-! activity is 
associated with increased intravascular thrombosis at the 
site of medial injury. Although transient plasminogen acti-
vator inhibitor-! elevation is not uncommon, its adverse 
effect appears to be expressed only in the presence of deep 
vessel wall injury. The procoagulant role of increased plas-
minogen activator inhibitor-! activity was established only 
indirectly, because vessel wall injury is associated with other 
prothrombotic mechanisms, such as platelet activation (10) 
and thrombin generation (11). Additional studies using anti-
platelet agents (for example, aspirin and monoclonal anti-
bodies against lib/Ilia receptors) or antithrombotic agents 
(for example, hirudin) will be needed to elucidate further the 
source of elevated plasminogen activator inhibitor-! activity 
and its response to therapy. Moreover, it remains to be 
determined if a similar phenomenon exists not only in 
patients with spontaneous vessel wall injury (1) but also in 
patients undergoing an intracoronary intervention such as 
angioplasty or atherectomy. 
Conclusions. Experimental deep vessel wall injury is 
associated with impaired fibrinolytic activity. In addition to 
other procoagulant factors, increased plasminogen activator 
inhibitor-! activity in plasma can contribute to increased risk 
of intravascular thrombosis and impaired resolution of 
thrombus. 
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